Patents by Inventor Lene Andresen

Lene Andresen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the Preparation of Insulin-Zinc Complexes
    Publication number: 20240307503
    Abstract: The invention concerns a process for preparing a pharmaceutical formulation comprising an insulin derivative, wherein the process comprises dissolving an insulin derivative in water, adjusting the pH of the solution to a pH above 7.2, adding a zinc solution while stirring continuously and adjusting the pH to the target pH of the formulation.
    Type: Application
    Filed: May 24, 2024
    Publication date: September 19, 2024
    Inventors: Lene Andresen, Rosa Rebecca Erritzoee Hansen, Per Jeppesen
  • Process for the Preparation of Insulin-Zinc Complexes
    Publication number: 20210060132
    Abstract: The invention concerns a process for preparing a pharmaceutical formulation comprising an insulin derivative, wherein the process comprises dissolving an insulin derivative in water, adjusting the pH of the solution to a pH above 7.2, adding a zinc solution while stirring continuously and adjusting the pH to the target pH of the formulation.
    Type: Application
    Filed: August 12, 2020
    Publication date: March 4, 2021
    Inventors: Lene Andresen, Rosa Rebecca Erritzoee Hansen, Per Jeppesen
  • Process for the Preparation of Insulin-Zinc Complexes
    Publication number: 20170165327
    Abstract: The invention concerns a process for preparing a pharmaceutical formulation comprising an insulin derivative, wherein the process comprises dissolving an insulin derivative in water, adjusting the pH of the solution to a pH above 7.2, adding a zinc solution while stirring continuously and adjusting the pH to the target pH of the formulation.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 15, 2017
    Inventors: Lene Andresen, Rosa Rebecca Erritzoee Hansen, Per Jeppesen
  • Process for the Preparation of Insulin-Zinc Complexes
    Publication number: 20150250857
    Abstract: The invention concerns a process for preparing a pharmaceutical formulation comprising an insulin derivative, wherein the process comprises dissolving an insulin derivative in water, adjusting the pH of the solution to a pH above 7.2, adding a zinc solution while stirring continuously and adjusting the pH to the target pH of the formulation.
    Type: Application
    Filed: March 19, 2015
    Publication date: September 10, 2015
    Inventors: Lene Andresen, Rosa Rebecca Erritzoee Hansen, Per Jeppesen
  • Process for the Preparation of Insulin-Zinc Complexes
    Publication number: 20130143803
    Abstract: The invention concerns a process for preparing a pharmaceutical formulation comprising an insulin derivative, wherein the process comprises dissolving an insulin derivative in water, adjusting the pH of the solution to a pH above 7.2, adding a zinc solution while stirring continuously and adjusting the pH to the target pH of the formulation.
    Type: Application
    Filed: May 9, 2011
    Publication date: June 6, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Lene Andresen, Rosa Rebecca Erritzoee Hansen, Per Jeppesen
  • CRYSTALLINE COMPOSITION CONTAINING ESCITALOPRAM
    Publication number: 20080305164
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: August 22, 2008
    Publication date: December 11, 2008
    Applicant: H. LUNDBECK A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Patent number: 7420069
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Grant
    Filed: February 7, 2005
    Date of Patent: September 2, 2008
    Assignee: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Patent number: 6916941
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: July 12, 2005
    Assignee: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Publication number: 20050147674
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: February 7, 2005
    Publication date: July 7, 2005
    Inventors: Troels Christensen, Ken Liljegren, Michiel Elema, Lene Andresen, Shashank Mahashabde, Sebastian Assenza
  • Granular preparations of gaboxadol
    Publication number: 20040157876
    Abstract: The present invention relates to a granulated product containing gaboxadol as an acid addition salt, a melt granulation process for the preparation thereof and to solid pharmaceutical unit dosage forms prepared from said granular preparation of gaboxadol.
    Type: Application
    Filed: February 18, 2004
    Publication date: August 12, 2004
    Inventors: Michiel O Elema, Lene Andresen, Per Holm
  • Crystalline composition containing escitalopram
    Publication number: 20030212128
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 &mgr;m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: March 31, 2003
    Publication date: November 13, 2003
    Applicant: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza